Health & biotech · AI
I.W.G. Inc.
AI referral agents and cloud technology for interoperable healthcare data and referral workflows.

Expert perspectives, founder stories, and data-driven insights for early-stage builders.

Discover how Antler founders are solving the world’s biggest challenges, from idea to scale.

See when new cohorts begin and find the right moment to start building with Antler.
Antler Japan · Tokyo
Antler Japan is a multi-stage venture investor that invests from inception to exit. We invest at Day Zero in founders building category-defining companies for Japan and global markets.
Who we are
Antler Japan gives founders a focused starting point to build fast and access capital. From Tokyo, we bring global reach, practical company-building support, and early conviction to the first day of a company.
Antler was founded in 2017 and operates across 27 locations in 22 countries. Antler has backed more than 2,000 companies and was named the world’s most active AI investor in 2024 by Dealroom.

Antler by the numbers
Japan portfolio
Antler Japan invests at company formation through the Antler Japan Residency. We are industry-agnostic: our portfolio includes companies across diverse industries and technologies, united by the ambition to solve consequential problems in Japan and globally.
Health & biotech · AI
AI referral agents and cloud technology for interoperable healthcare data and referral workflows.
Health & biotech · AI
MedGen Japan provides a reliable AI assistant for practical medical knowledge.
Industrial · robotics
AI that learns and adapts while moving for drones, robots, and industrial systems.
B2B software · space tech
Technology designed to reduce satellite collision risk and maximise constellation performance.
Industrial · robotics
Bipedal robots designed to improve the efficiency of postal operations.
B2B software · construction
Physical AI for safer, more productive construction sites.
B2B software · robotics compliance
An end-to-end compliance engine that accelerates robot certification and readiness for market.
Health & biotech · regenerative medicine
Wound-care materials for regenerative medicine designed to promote healing while lowering infection risk.
B2B software · knowledge management
Organisation memory for professional services operating in the era of commoditised AI.
“Antler was more than a VC. The team gave us practical advice to aim higher, build a compelling pitch, and think bigger from day one.”Manjunatha Chandrappa · Co-founder & CEO, Antler Japan Cohort
“Our experience at the Antler Residency program was highly valuable. We improved significantly as a company, particularly in understanding how to effectively communicate with investors.”Xiaoyan Zhou · Founder & CEO, Antler Japan Cohort
For founders
Fewer than 5% of applicants are selected. The Antler Japan Residency is the starting point for founders building globally relevant companies. The next Residency begins on November 2, 2026 in Tokyo.
Spend six focused weeks with exceptional founders in Tokyo. This is not classroom training; it is six weeks to accelerate your company with partners who have built and scaled startups.
Investment committee-approved companies receive US$150,000 for 10% equity: US$100,000 in equity and a US$50,000 uncapped SAFE with MFN. Antler can provide follow-on matching capital and up to US$25 million through Antler Elevate.
Apply through the Antler portal. Teams with a clear problem, customer insight, or early hypothesis gain the most from the Residency.
We look for teams with specific profiles and the conviction to build beyond a local optimum.
For investors
Antler Japan gives Series A and growth investors a consistent source of high-quality, pre-screened deal flow. Residency participants are selected from fewer than 5% of applicants and Antler invests with conviction from company formation.
VCs, CVCs, and angel investors can connect with Antler Japan to explore co-investment and portfolio introductions.
Common questions
Masterclasses and guest-speaker sessions are usually held in English. Antler Japan supports English and Japanese during one-to-one meetings with partners, and the Antler Japan team is bilingual.
Antler Japan invests at company formation through the Antler Japan Residency. Investment committee-approved companies receive US$150,000 for 10% equity after the six-week Residency — structured as $100K equity plus a $50K uncapped SAFE with MFN.
No. Applicants need a clear problem, a customer insight, or an initial hypothesis to validate. A finished product is not required.
There is no programme fee. Founders are responsible for their travel and living costs during the six-week Tokyo Residency.
Yes. The Antler Japan Residency is a full-time, in-person programme in Tokyo.
Antler does not sponsor visas directly, but the team can introduce founders to trusted third parties that provide paid visa-application support.
The team
Co-founder & Managing Partner
Leads Antler’s APAC investment activity and works with founders from inception through scale.
Senior Director
Works with founders building in Japan, drawing on global innovation and venture experience.
Startup Scouting Manager
Finds the next generation of deep-tech founders for Antler Japan.
Programme Manager
Supports founders from the first conversation through investment.
Venture Partner
Co-founder and chairman of Zehitomo, a Japanese local-services marketplace.
Next cohort · Tokyo · Starts November 2, 2026
Join exceptional co-founders in Tokyo. Build fast, access capital, and scale for the world.